Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top

Current Treatment Options in Oncology

2000 - 2024
Volumes
187
Issues
Chevron right icon
Issue 4/2024
Latest issue

Current Treatment Options in Oncology OnlineFirst articles

Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods

Open Access Anthracycline

Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?

Diffuse Large B-Cell Lymphoma

Molecular Heterogeneity in Leiomyosarcoma and Implications for Personalised Medicine

Soft Tissue Sarcoma

Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?

Glioblastoma

Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer

Prostate Cancer Correction

Photodynamic application in diagnostic procedures and treatment of non-melanoma skin cancers

Basalioma

Role of Metastasis-Directed Therapy in Genitourinary Cancers

Prostate Cancer

HER2-Positive Metastatic Colorectal Cancer

Trastuzumab

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

About this journal

Current Treatment Options in Oncology offers in-depth review articles contributed by international experts on the most significant developments in the field. By providing clear, insightful, balanced review articles that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the treatment of cancer.

Metadata
Title
Current Treatment Options in Oncology
Coverage
Volume 1/2000 - Volume 25/2024
Publisher
Springer US
Electronic ISSN
1534-6277
Print ISSN
1527-2729
Journal ID
11864
DOI
https://doi.org/10.1007/11864.1534-6277
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits